APO Research
Talk to an analyst

APO RESEARCH · REPORT

Avanafil Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Avanafil Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025188 pages

Choose your research edition.

Industry ResearchAvanafil Tablets Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Avanafil Tablets Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Avanafil Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Avanafil Tablets Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Avanafil Tablets Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Avanafil Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Avanafil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Avanafil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Avanafil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Avanafil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Avanafil Tablets include VIVUS, Sanofi, Huilun Pharmaceutical, Haisco Pharmaceutical, Menarini Group, JW Pharmaceutical, Endo International and Auxilium Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Avanafil Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Avanafil Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Avanafil Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Avanafil Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Avanafil Tablets Segment by Company

VIVUS

Sanofi

Huilun Pharmaceutical

Haisco Pharmaceutical

Menarini Group

JW Pharmaceutical

Endo International

Auxilium Pharmaceuticals

Avanafil Tablets Segment by Type

50 mg

100 mg

200 mg

Avanafil Tablets Segment by Application

18-45 Years Old

46-60 Years Old

Other

Avanafil Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Avanafil Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Avanafil Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Avanafil Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Avanafil Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Avanafil Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Avanafil Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Avanafil Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Avanafil Tablets Industry Trends Table 2. Avanafil Tablets Industry Drivers Table 3. Avanafil Tablets Industry Opportunities and Challenges Table 4. Avanafil Tablets Industry Restraints Table 5. Global Avanafil Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Avanafil Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Avanafil Tablets Sales by Manufacturers (kg) & (2021-2026) Table 8. Global Avanafil Tablets Sales Market Share by Manufacturers Table 9. Global Avanafil Tablets Average Sales Price (USD/g) of Manufacturers (2021-2026) Table 10. Global Avanafil Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Avanafil Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Avanafil Tablets Manufacturers, Product Type & Application Table 13. Global Avanafil Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Avanafil Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50 mg Table 17. Major Manufacturers of 100 mg Table 18. Major Manufacturers of 200 mg Table 19. Global Avanafil Tablets Sales by Type 2021 VS 2025 VS 2032 (kg) Table 20. Global Avanafil Tablets Sales by Type (2021-2026) & (kg) Table 21. Global Avanafil Tablets Sales by Type (2027-2032) & (kg) Table 22. Global Avanafil Tablets Sales Market Share by Type (2021-2026) Table 23. Global Avanafil Tablets Sales Market Share by Type (2027-2032) Table 24. Global Avanafil Tablets Revenue by Type 2021 VS 2025 VS 2032 (kg) Table 25. Global Avanafil Tablets Revenue by Type (2021-2026) & (kg) Table 26. Global Avanafil Tablets Revenue by Type (2027-2032) & (kg) Table 27. Global Avanafil Tablets Revenue Market Share by Type (2021-2026) Table 28. Global Avanafil Tablets Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of 18-45 Years Old Table 30. Major Manufacturers of 46-60 Years Old Table 31. Major Manufacturers of Other Table 32. Global Avanafil Tablets Sales by Application 2021 VS 2025 VS 2032 (kg) Table 33. Global Avanafil Tablets Sales by Application (2021-2026) & (kg) Table 34. Global Avanafil Tablets Sales by Application (2027-2032) & (kg) Table 35. Global Avanafil Tablets Sales Market Share by Application (2021-2026) Table 36. Global Avanafil Tablets Sales Market Share by Application (2027-2032) Table 37. Global Avanafil Tablets Revenue by Application 2021 VS 2025 VS 2032 (kg) Table 38. Global Avanafil Tablets Revenue by Application (2021-2026) & (kg) Table 39. Global Avanafil Tablets Revenue by Application (2027-2032) & (kg) Table 40. Global Avanafil Tablets Revenue Market Share by Application (2021-2026) Table 41. Global Avanafil Tablets Revenue Market Share by Application (2027-2032) Table 42. Global Avanafil Tablets Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 43. Global Avanafil Tablets Sales by Region (2021-2026) & (kg) Table 44. Global Avanafil Tablets Sales Market Share by Region (2021-2026) Table 45. Global Avanafil Tablets Sales Forecasted by Region (2027-2032) & (kg) Table 46. Global Avanafil Tablets Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Avanafil Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 48. North America Avanafil Tablets Sales by Country (2021-2026) & (kg) Table 49. North America Avanafil Tablets Sales by Country (2027-2032) & (kg) Table 50. Europe Avanafil Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 51. Europe Avanafil Tablets Sales by Country (2021-2026) & (kg) Table 52. Europe Avanafil Tablets Sales by Country (2027-2032) & (kg) Table 53. Asia Pacific Avanafil Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 54. Asia Pacific Avanafil Tablets Sales by Country (2021-2026) & (kg) Table 55. Asia Pacific Avanafil Tablets Sales by Country (2027-2032) & (kg) Table 56. South America, Middle East and Africa Avanafil Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 57. South America, Middle East and Africa Avanafil Tablets Sales by Country (2021-2026) & (kg) Table 58. South America, Middle East and Africa Avanafil Tablets Sales by Country (2027-2032) & (kg) Table 59. Global Avanafil Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Avanafil Tablets Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Avanafil Tablets Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Avanafil Tablets Revenue Market Share by Region (2021-2026) Table 63. Global Avanafil Tablets Revenue Market Share by Region (2027-2032) Table 64. VIVUS Company Information Table 65. VIVUS Business Overview Table 66. VIVUS Avanafil Tablets Sales (kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. VIVUS Avanafil Tablets Product Portfolio Table 68. VIVUS Recent Development Table 69. Sanofi Company Information Table 70. Sanofi Business Overview Table 71. Sanofi Avanafil Tablets Sales (kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sanofi Avanafil Tablets Product Portfolio Table 73. Sanofi Recent Development Table 74. Huilun Pharmaceutical Company Information Table 75. Huilun Pharmaceutical Business Overview Table 76. Huilun Pharmaceutical Avanafil Tablets Sales (kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Huilun Pharmaceutical Avanafil Tablets Product Portfolio Table 78. Huilun Pharmaceutical Recent Development Table 79. Haisco Pharmaceutical Company Information Table 80. Haisco Pharmaceutical Business Overview Table 81. Haisco Pharmaceutical Avanafil Tablets Sales (kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Haisco Pharmaceutical Avanafil Tablets Product Portfolio Table 83. Haisco Pharmaceutical Recent Development Table 84. Menarini Group Company Information Table 85. Menarini Group Business Overview Table 86. Menarini Group Avanafil Tablets Sales (kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Menarini Group Avanafil Tablets Product Portfolio Table 88. Menarini Group Recent Development Table 89. JW Pharmaceutical Company Information Table 90. JW Pharmaceutical Business Overview Table 91. JW Pharmaceutical Avanafil Tablets Sales (kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. JW Pharmaceutical Avanafil Tablets Product Portfolio Table 93. JW Pharmaceutical Recent Development Table 94. Endo International Company Information Table 95. Endo International Business Overview Table 96. Endo International Avanafil Tablets Sales (kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Endo International Avanafil Tablets Product Portfolio Table 98. Endo International Recent Development Table 99. Auxilium Pharmaceuticals Company Information Table 100. Auxilium Pharmaceuticals Business Overview Table 101. Auxilium Pharmaceuticals Avanafil Tablets Sales (kg), Price (USD/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Auxilium Pharmaceuticals Avanafil Tablets Product Portfolio Table 103. Auxilium Pharmaceuticals Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Avanafil Tablets Distributors List Table 107. Avanafil Tablets Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Avanafil Tablets Product Image Figure 2. Global Avanafil Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Avanafil Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Avanafil Tablets Sales (2021-2032) & (kg) Figure 5. Global Avanafil Tablets Average Price (USD/g) & (2021-2032) Figure 6. Global Top 5 and 10 Avanafil Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50 mg Image Figure 9. 100 mg Image Figure 10. 200 mg Image Figure 11. Global Avanafil Tablets Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 12. Global Avanafil Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Avanafil Tablets Sales Market Share by Type (2021-2032) Figure 14. Global Avanafil Tablets Revenue by Type (2021 VS 2025 VS 2032) & (kg) Figure 15. Global Avanafil Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Avanafil Tablets Revenue Market Share by Type (2021-2032) Figure 17. 18-45 Years Old Image Figure 18. 46-60 Years Old Image Figure 19. Other Image Figure 20. Global Avanafil Tablets Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 21. Global Avanafil Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Avanafil Tablets Sales Market Share by Application (2021-2032) Figure 23. Global Avanafil Tablets Revenue by Application (2021 VS 2025 VS 2032) & (kg) Figure 24. Global Avanafil Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Avanafil Tablets Revenue Market Share by Application (2021-2032) Figure 26. North America Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 27. North America Avanafil Tablets Sales Market Share by Country (2021-2032) Figure 28. U.S. Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 29. Canada Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 30. Mexico Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 31. Europe Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 32. Europe Avanafil Tablets Sales Market Share by Country (2021-2032) Figure 33. Germany Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 34. France Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 35. U.K. Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 36. Italy Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 37. Netherlands Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 38. Asia Pacific Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 39. Asia Pacific Avanafil Tablets Sales Market Share by Country (2021-2032) Figure 40. China Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 41. Japan Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 42. South Korea Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 43. Southeast Asia Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 44. India Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 45. Australia Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 46. South America, Middle East and Africa Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 47. South America, Middle East and Africa Avanafil Tablets Sales Market Share by Country (2021-2032) Figure 48. Brazil Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 49. South Africa Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 50. Saudi Arabia Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 51. Turkey Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 52. Argentina Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 53. UAE Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 54. Egypt Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 55. Chile Avanafil Tablets Sales and Growth Rate (2021-2032) & (kg) Figure 56. Global Avanafil Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Avanafil Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Avanafil Tablets Revenue (2021-2032) & (US$ Million) Figure 59. North America Avanafil Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Avanafil Tablets Revenue (2021-2032) & (US$ Million) Figure 61. Europe Avanafil Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Avanafil Tablets Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Avanafil Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Avanafil Tablets Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Avanafil Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Avanafil Tablets Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Avanafil Tablets Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 50 mg
  • 100 mg
  • 200 mg
Applications
  • 18-45 Years Old
  • 46-60 Years Old
  • Other
Companies covered
  • VIVUS
  • Sanofi
  • Huilun Pharmaceutical
  • Haisco Pharmaceutical
  • Menarini Group
  • JW Pharmaceutical
  • Endo International
  • Auxilium Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Avanafil Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Avanafil Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Avanafil Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Avanafil Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Avanafil Tablets Market Dynamics
  1. 2.1 Avanafil Tablets Industry Trends
  2. 2.2 Avanafil Tablets Industry Drivers
  3. 2.3 Avanafil Tablets Industry Opportunities and Challenges
  4. 2.4 Avanafil Tablets Industry Restraints
3 Avanafil Tablets Market by Manufacturers
  1. 3.1 Global Avanafil Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Avanafil Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Avanafil Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Avanafil Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Avanafil Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Avanafil Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Avanafil Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Avanafil Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Avanafil Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Avanafil Tablets Tier 1, Tier 2, and Tier 3
4 Avanafil Tablets Market by Type
  1. 4.1 Avanafil Tablets Type Introduction
  2. 4.1.1 50 mg
  3. 4.1.2 100 mg
  4. 4.1.3 200 mg
  5. 4.2 Global Avanafil Tablets Sales by Type
  6. 4.2.1 Global Avanafil Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Avanafil Tablets Sales by Type (2021-2032)
  8. 4.2.3 Global Avanafil Tablets Sales Market Share by Type (2021-2032)
  9. 4.3 Global Avanafil Tablets Revenue by Type
  10. 4.3.1 Global Avanafil Tablets Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Avanafil Tablets Revenue by Type (2021-2032)
  12. 4.3.3 Global Avanafil Tablets Revenue Market Share by Type (2021-2032)
5 Avanafil Tablets Market by Application
  1. 5.1 Avanafil Tablets Application Introduction
  2. 5.1.1 18-45 Years Old
  3. 5.1.2 46-60 Years Old
  4. 5.1.3 Other
  5. 5.2 Global Avanafil Tablets Sales by Application
  6. 5.2.1 Global Avanafil Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Avanafil Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Avanafil Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Avanafil Tablets Revenue by Application
  10. 5.3.1 Global Avanafil Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Avanafil Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Avanafil Tablets Revenue Market Share by Application (2021-2032)
6 Global Avanafil Tablets Sales by Region
  1. 6.1 Global Avanafil Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Avanafil Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Avanafil Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Avanafil Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Avanafil Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Avanafil Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Avanafil Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Avanafil Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Avanafil Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Avanafil Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Avanafil Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Avanafil Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Avanafil Tablets Revenue by Region
  1. 7.1 Global Avanafil Tablets Revenue by Region
  2. 7.1.1 Global Avanafil Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Avanafil Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Avanafil Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Avanafil Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Avanafil Tablets Revenue (2021-2032)
  8. 7.2.2 North America Avanafil Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Avanafil Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Avanafil Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Avanafil Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Avanafil Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Avanafil Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Avanafil Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 VIVUS
  2. 8.1.1 VIVUS Company Information
  3. 8.1.2 VIVUS Business Overview
  4. 8.1.3 VIVUS Avanafil Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 VIVUS Avanafil Tablets Product Portfolio
  6. 8.1.5 VIVUS Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Avanafil Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Avanafil Tablets Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Huilun Pharmaceutical
  14. 8.3.1 Huilun Pharmaceutical Company Information
  15. 8.3.2 Huilun Pharmaceutical Business Overview
  16. 8.3.3 Huilun Pharmaceutical Avanafil Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Huilun Pharmaceutical Avanafil Tablets Product Portfolio
  18. 8.3.5 Huilun Pharmaceutical Recent Developments
  19. 8.4 Haisco Pharmaceutical
  20. 8.4.1 Haisco Pharmaceutical Company Information
  21. 8.4.2 Haisco Pharmaceutical Business Overview
  22. 8.4.3 Haisco Pharmaceutical Avanafil Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Haisco Pharmaceutical Avanafil Tablets Product Portfolio
  24. 8.4.5 Haisco Pharmaceutical Recent Developments
  25. 8.5 Menarini Group
  26. 8.5.1 Menarini Group Company Information
  27. 8.5.2 Menarini Group Business Overview
  28. 8.5.3 Menarini Group Avanafil Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Menarini Group Avanafil Tablets Product Portfolio
  30. 8.5.5 Menarini Group Recent Developments
  31. 8.6 JW Pharmaceutical
  32. 8.6.1 JW Pharmaceutical Company Information
  33. 8.6.2 JW Pharmaceutical Business Overview
  34. 8.6.3 JW Pharmaceutical Avanafil Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 JW Pharmaceutical Avanafil Tablets Product Portfolio
  36. 8.6.5 JW Pharmaceutical Recent Developments
  37. 8.7 Endo International
  38. 8.7.1 Endo International Company Information
  39. 8.7.2 Endo International Business Overview
  40. 8.7.3 Endo International Avanafil Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Endo International Avanafil Tablets Product Portfolio
  42. 8.7.5 Endo International Recent Developments
  43. 8.8 Auxilium Pharmaceuticals
  44. 8.8.1 Auxilium Pharmaceuticals Company Information
  45. 8.8.2 Auxilium Pharmaceuticals Business Overview
  46. 8.8.3 Auxilium Pharmaceuticals Avanafil Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Auxilium Pharmaceuticals Avanafil Tablets Product Portfolio
  48. 8.8.5 Auxilium Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Avanafil Tablets Value Chain Analysis
  2. 9.1.1 Avanafil Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Avanafil Tablets Production Mode & Process
  6. 9.2 Avanafil Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Avanafil Tablets Distributors
  9. 9.2.3 Avanafil Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst